New Expanded Indication Could Change the TAVR Narrative
Now Edwards and Medtronic’s transcatheter aortic valve replacement devices can be used in patients with low-risk for death or major complications associated with open-heart surgery. One analyst said the conversation will eventually shift toward TAVR being the “preferred treatment method.”
Concept Medical Has the ‘MagicTouch’ to Treat PAD
The Tampa, FL-based company has received breakthrough device designation from FDA for the MagicTouch PTA, a Sirolimus drug-coated balloon (DCB) catheter. The designation comes a few short days after Becton Dickinson and Co. said FDA rejected its Lutonix Paclitaxel DCB for PAD BTK.
MIT Model Automates AI for Medical Decision-Making
MIT computer scientists are hoping to accelerate the use of artificial intelligence to improve medical decision-making, by automating a key step that’s usually done by hand — and that’s becoming more laborious as certain datasets grow ever-larger.
How 2019 Will Define TAVR for Years to Come
New approvals; product withdrawals; and a high profile procedure could easily cause 2019 to be one of the most memorable years for TAVR.
May the Best Spine Robot Win
Dave Demski, CEO of Globus Medical, said it is taking longer to sell robotic systems due to increasing competitive marketing initiatives. Hospital executives are taking longer to make the purchasing decision as they evaluate potential alternatives, he said.
What Could Blockchain Technologies Mean for the Medical Device Industry?
Blockchain offers a number of potential use cases, but there are some challenges to overcome.
The Robots Are Coming, Are You Ready?
The surgical robotics landscape is moving at a lightening pace, with more and more entrants each year. What will this mean for medtech?
Glaukos’ iStent Has Strong Showing in 5-Year Data
Results from the prospective, randomized, controlled, multi-surgeon clinical trial were published in Ophthalmology Glaucoma.
4 Medtech Innovations That Are Tearing up the Script
In a new report, DRG experts have highlighted four medtech innovations that they see tearing up the script.
NGS and IVD Manufacturer Team up to Improve Clinical Trials
Cellgen Diagnostics and Genomic Testing Cooperative announced a collaboration that promises to provide the pharmaceutical industry with the seamless integration of biomarker discovery, validation, and IVD development.
